Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05824273 · ClinicalTrials.gov registry record · NA
The INSPIRE-Lung Study
A NA study, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT05824273 is a NA study that has completed, run by Hackensack Meridian Health. The registered enrollment target is 512 participants.
The verdict
NCT05824273, a NA study, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.
Interventions
- BEHAVIORAL LungTalk
- BEHAVIORAL Non-tailored intervention - Standard of practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05824273
The ClinicalTrials.gov registry entry for NCT05824273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LungTalk is the first listed.
NCT05824273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05824273 about?
NCT05824273 is a clinical study titled "The INSPIRE-Lung Study". LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals ...
What is the current status of trial NCT05824273?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2023-08-02. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT05824273?
The interventions under investigation include: LungTalk (BEHAVIORAL), Non-tailored intervention - Standard of practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05824273?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.